MEDIUM confidence: 100% data completeness, but the composite (53) sits in the indecisive 30–70 range — strong-buy and short calls require a more decisive composite. What does confidence mean?
Technical context for active traders — derived from price, the 50/200-day moving averages, the 52-week range, and recent volume. Not part of the QScore.
Not enough return history to estimate factor exposures — 29 of 36 months required. This stock is too recently listed (or has too short a price history) for a reliable Fama-French regression.
AI classification of policy/regulatory sensitivity from the company's sector, industry, and business description. Exposure/sensitivity only — not a political opinion, a prediction of government action, or investment advice. As of 2026-07-10.
Dated events from the market calendar; the “also watch” items are AI-generated observations from QScoring data. Informational only — not investment advice, and dates can change.
Avg target $78 (last qtr, 12 analysts) → $77 (last mo, 3) (-1.8%).
Buy-rated share 100% → 100% over ~3 months (+0pp).
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jul 2026 | $0.40 | $0.45 | +13.6% |
| May 2026 | $0.29 | $0.39 | +34.5% |
| Feb 2026 | $0.34 | $0.33 | -2.9% |
| Oct 2025 | $0.26 | $0.30 | +13.9% |
| Aug 2025 | $0.19 | $0.22 | +15.8% |
| May 2025 | $0.08 | $0.19 | +137.5% |
| Mar 2025 | $0.19 | $0.22 | +15.8% |
| Nov 2024 | $0.18 | $0.11 | -38.9% |
| Metric (USD) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $6.7B— | $7.7B+15.3% | $8.8B+14.3% | $11.3B+27.6% | $12.9B+14.6% |
| EPS (dil.) | $0.29— | $-0.31-206.9% | $-0.90n/m | $-0.09n/m | $0.87n/m |
| Free Cash Flow | $211M— | -$75M-135.5% | $137Mn/m | -$57M-141.6% | $395Mn/m |
| Gross Margin | 18.6% | 17.5%-1.1pp | 16.2%-1.3pp | 14.1%-2.1pp | 11.8%-2.3pp |
| Operating Margin | 3.5% | 2.4%-1.1pp | 1.7%-0.8pp | 1.8%+0.2pp | 2.3%+0.5pp |
| Net Margin | 0.7% | -0.7%-1.4pp | -1.8%-1.1pp | -0.2%+1.6pp | 1.5%+1.6pp |
Absolute figures with year-over-year change. Margins show the level with the change in percentage points (pp). “n/m” = not meaningful (prior ≤ 0); ⚠ marks a large percentage off a small base — read the dollar figure.
Net insider -$3.4B over 180 days (0 open-market buys, 11 sells). Insider buying is the informative signal; routine selling is normal.
Short interest, days-to-cover, and institutional-ownership change require a data-plan upgrade (not yet available).
Forward-return IC, quintile spread & hit rate publish on /performance as the tracking panel accrues enough no-look-ahead history.
Net buyback (repurchases less issuance) ÷ market cap, plus trailing dividend yield.
Working the DCF backward: holding the assumptions below, this is the free-cash-flow growth today's price implies over the next 10 years. It is a read on the price's embedded expectations — not a fair-value or target price.
The price implies FCF growth above the analyst consensus of 19.3%/yr (revenue basis).
Base free cash flow $158M (avg FY2023–FY2025; latest year $395M) · equity value $11.9B · levered FCF discounted at the cost of equity. Reverse DCF is illustrative, not advice.
The QScore of 53 indicates a neutral outlook for BTSG, driven by strong growth scores, with notable revenue and EPS growth of 14.6% and 1104.3%, respectively. However, this is offset by lower scores in value, due to a P/E of 42.4 and P/B of 6.1, and risk, with a beta of 1.9 and high 60-day volatility of 56.3%. The long-term and short-term scores are relatively aligned, with the short-term score slightly higher at 54, reflecting the stock's strong momentum, with a 12-month return of 179.6%.